CRBP
Corbus Pharmaceuticals Holdings
$9.08
−$0.09 (−0.98%)Jul 27, 2026
Key metrics
The numbers that frame CRBP today
- Market cap
- $168.23M
- P/E (TTM)
- -2.0
- EV / FCF
- -1.9
- ROIC
- -88.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $7.12
- 52wk High
- $20.56
Growth
Revenue and earnings trend for CRBP
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CRBP
Is Corbus Pharmaceuticals Holdings a good buy?
No. Corbus Pharmaceuticals Holdings has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Corbus Pharmaceuticals Holdings is selling at a very high price.
What is the market capitalization of CRBP?
Corbus Pharmaceuticals Holdings's market capitalization is $168.23M.
What is the P/E ratio for CRBP stock?
Corbus Pharmaceuticals Holdings's current P/E ratio is -2.
What is the 52-week high for CRBP stock?
The 52-week high for Corbus Pharmaceuticals Holdings is $20.56. The current close of $9.08 is 55.8% below that high.
What is the 52-week low for CRBP stock?
The 52-week low for Corbus Pharmaceuticals Holdings is $7.12. The current close of $9.08 is 27.5% above that low.
Does CRBP stock pay dividends?
Corbus Pharmaceuticals Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRBP?
Corbus Pharmaceuticals Holdings's Debt / Equity ratio is 0.01.